OPINION
1. The State appeals the trial court’s order suppressing the results of Defendant’s blood test. We determine that the results of Defendant’s blood test were protected by the physician-patient privilege, SCRA 1986, 11-504 (Repl.1994). We therefore affirm.
I. FACTUAL AND PROCEDURAL BACKGROUND
2. Defendant and a passenger were involved in a vehicular accident. Defendant lost control of his motorcycle when he hit either a pothole or a patch of gravel. Both he and the passenger sustained injuries requiring medical attention. A police officer questioned Defendant at the hospital. The officer testified not only that he smelled alcohol on Defendant’s breath and that Defendant had bloodshot, watery eyes, but also that Defendant admitted he had consumed two beers and had been speeding at the time of the accident. At some point, either before or after (or both before and after) the officer arrested Defendant, the officer asked Defendant if he would take a blood-alcohol test. 1 Defendant refused.
3. After Defendant had been treated for his injuries, the officer asked one of the nurses in the emergency room about the blood-alcohol content of the blood test taken by the hospital in the course of diagnosing and treating Defendant. The nurse stated that the tests showed Defendant’s blood-alcohol content to be .104. The State later subpoenaed the medical records. Defendant was eventually charged with operating a vehicle while under the influence of alcohol pursuant to NMSA 1978, Section 66-8-102 (Repl.Pamp.1994), and with causing great bodily injury while driving under the influence of alcohol pursuant to NMSA 1978, Section 66-8-101(B), (C) (Repl.Pamp.1994), among other infractions. After arguments before the trial court on Defendant’s motion to quash the grand jury indictmеnt and motion to suppress the results of the hospital’s blood test, the trial court concluded that, although the officer had probable cause to arrest Defendant, the results of the test constituted a privileged confidential communication between a physician and a patient under SCRA 11-504. The trial court thus suppressed the test results.
II. DISCUSSION
4. The material facts are not at issue, and the only dispute arises from the application of SCRA 11-504 and the law to the facts. We therefore review de novo. See State v. Attaway,
5. SCRA 11-504(B) states:
A patient has a privilege to refuse to disclose and to prevent any other person from disclosing confidential communications, made for the purposes of diagnosis or treatment of his physical, mental or emotional condition, including drug addiction, among himself, his physician or psychotherapist, or persons who are participating in the diagnosis or treatment under the direction of the physician or psychotherapist, including members of the patient’s family.
6. Common law did not recognize the physician-patient privilege. Trujillo v. Puro,
7. For the privilege to apply, the patient must have consulted the physician for treatment or diagnosis looking toward treatment. SCRA 11-504(B). Here, there is no question that Defendant consulted a physician to treat his injuries sustained in the motorcycle accident. There is likewise no dispute that Defendant was a patient. Cf. State, In the Interest of M.P.C.,
A. Did The Blood Test Constitute A Communication Under SCRA 11-504?
8. “Communication” is not defined in SCRA 11-504, and the precise issue of whether the results of a blood test constitute a confidential communication has never been addressed in New Mexico. However, in In re Doe,
9. The State argues that State v. Teel,
B. Was The Communication Confidential And Therefore Privileged?
10. SCRA 11-504(A)(4) defines a confidential communication:
A communication is “confidential” if not intended to be disclosed to third persons other than those present to further the interest of the patient in the consultation, examination or interview, or persons reasonably necessary for the transmission of the communication, or persons who are participating in the diagnosis and treatment under the direction of the physician or psychotheraрist, including members of the patient’s family.
11. Doe held that, to be confidential pursuant to this provision, two conditions must be met: (1) the patient must intend the communication to be undisclosed, and (2) non-disclosure would further the interest of the patient.
2
Id. at 446,
12. Regarding the first prong, the rule implies that the intent must be expressed to medical personnel involved in the diagnosis or treatment of the patient. Although the rule does not indicate how intent is to be demonstrated by the patient, intent was described in In re Sherry C. & John M.,
13. Regarding the second prong, nondisclosure would further the interest of Defendant because it would prevent others from learning personal information about Defendant’s health and well-being. A blood test taken for diagnosis and treatment can reveal a tremendous amount of information about a patient, including the existence of disease, illness, or drug addiction. Keeping the results confidential gives the patient the power to reveal the private information to the persons the patient chooses, reinforcing the privilege’s policy of patient autonomy and privacy. For those reasons, nondisclosure of the results of Defendant’s blood test here would further his privacy interest. Thus, because both prongs were satisfied, we determine that the results of Defendant’s blood test сonstituted a confidential communication.
C. If Defendant’s Blood Test Constituted A Confidential Communication, Did The Officer Have Access To It Under SCRA 11-504(D)(3), An Exception To The General Rule?
14. SCRA 11-504(D)(3) states:
There is no privilege under this rule as to communications relevant to an issue of the physical, mental or emotional condition of the patient in any proceeding in which he relies upon the condition as an element of his claim or defense, or, after the patient’s death, in any proceeding in which any party relies upon the condition as an element of his claim or defense.
15. The State argues that, because Defendant’s physical condition was at issue, he lost his privilege under this exceptiоn. According to this provision, however, the exception will apply only if the communication is relevant to an “element of [the patient’s] claim or defense.” Id. Here Defendant did not make a claim or offer a defense. He simply stated that he was not guilty of the charges, and it was the State’s burden to prove the criminal charges beyond a reasonable doubt. Cf. State v. Berry,
16. Our holding today is limited to the question of whether Defendant’s not guilty plea waived the privilege. We acknowledge, but do not decide, that under SCRA 11-504(D)(3) the physician-patient privilege may be deemed waived if a defendant testifies at trial and denies operating a motor vehicle while under the influence of alcohol. See McVay v. State,
III. PUBLIC POLICY CONCERNS
17. In so holding, we are mindful of the severe drunk-driving problems in New Mexico. “Driving while intoxicated, with its great potential for serious injury or death, undeniably represents a reckless and inexcusable disregard for the rights of other members of the travelling public.” Dress,
18. We do note, however, that, despite the privilege of SCRA 11-504, the State is not left without measures to pursue its objective of getting drunk drivers off the road. First, if a suspected pеrson refuses to disclose the results of a blood test and refuses to take any other test, the suspect automatically loses his license for a year under our implied consent statute. See § 66-8-lll(B) (Repl.Pamp.1994). Second, if the trial court should determine from other evidence of intoxication that a defendant was under the influence, that defеndant will be charged with an aggravated DWI based on a refusal to perform the tests. See § 66-8-102(D)(3); see also State ex rel. Schwartz v. Kennedy,
IV. CONCLUSION
19. We hold that Defendant’s conduct demonstratеd an intent to keep the results of his blood test confidential. We also hold that Defendant did not place an element of his defense at issue by simply pleading not guilty. We therefore conclude that the results of the blood test were protected from disclosure under SCRA 11-504 and were properly suppressed. The trial court’s judgment is therefore аffirmed.
20. IT IS SO ORDERED.
Notes
. The answer brief, the motion to suppress, and the police officer's testimony make overlapping, and sometimes contradictory, statements about the sequence of the request and the arrest. The precise timeline, however, is not essential to our analysis.
. It is not clear from Doe whether the Court derived the two-part test frоm the provision noted above. We do not read the language of the rule as mandating the second prong of the Doe test. Instead, we believe the phrase “to further the interest of the patient” refers to "those present,” not to whether nondisclosure of the substance of the communication would further the patient’s interest. Neverthеless, we agree with Doe’s two-part test, irrespective of its derivation. A confidential communication in our view would be a communication related to diagnosis or treatment, see SCRA 11-504(B); Wigmore, supra, at § 2383, that a reasonable person in the patient’s circumstances would not want divulged to people other than those listed in SCRA 11-504(A)(4). See Wigmоre, supra, at § 2381 (confidentiality should be inferred according to circumstances of each case). In other words, and as Doe provides, nondisclosure of the communication would further the interest of the particular patient.
. Doe, in contrast, stated that, in order for a communication to be intended as confidential, the intent "must be mаnifested in some fashion with words or words and conduct [that] lead a psychotherapist to understand or believe that the information obtained was intended to be confidential.”
